Burcu Saka
Title
Cited by
Cited by
Year
Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases
O Basturk, L Tang, RH Hruban, NV Adsay, Z Yang, AM Krasinskas, ...
The American journal of surgical pathology 38 (4), 437, 2014
1602014
Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas
JC Roa, O Tapia, A Cakir, O Basturk, N Dursun, D Akdemir, B Saka, ...
Modern Pathology 24 (8), 1069-1078, 2011
1302011
Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies
MD Reid, P Bagci, N Ohike, B Saka, IE Seven, N Dursun, S Balci, H Gucer, ...
Modern Pathology 28 (5), 686-694, 2015
1192015
Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies
MD Reid, P Bagci, N Ohike, B Saka, IE Seven, N Dursun, S Balci, H Gucer, ...
Modern Pathology 28 (5), 686-694, 2015
1192015
Neuroendocrine tumors of the pancreas: current concepts and controversies
MD Reid, S Balci, B Saka, NV Adsay
Endocrine pathology 25 (1), 65-79, 2014
1162014
Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-stage protocol inapplicable and …
B Saka, S Balci, O Basturk, P Bagci, LM Postlewait, S Maithel, J Knight, ...
Annals of surgical oncology 23 (6), 2010-2018, 2016
702016
Pronecrotic mixed lineage kinase domain‐like protein expression is a prognostic biomarker in patients with early‐stage resected pancreatic adenocarcinoma
LE Colbert, SB Fisher, CW Hardy, WA Hall, B Saka, JW Shelton, ...
Cancer 119 (17), 3148-3155, 2013
672013
Substaging of lymph node status in resected pancreatic ductal adenocarcinoma has strong prognostic correlations: proposal for a revised N classification for TNM staging
O Basturk, B Saka, S Balci, LM Postlewait, J Knight, M Goodman, D Kooby, ...
Annals of surgical oncology 22 (3), 1187-1195, 2015
612015
Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications
MD Reid, B Saka, S Balci, AS Goldblum, NV Adsay
American journal of clinical pathology 141 (2), 168-180, 2014
582014
Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of …
NV Adsay, O Basturk, B Saka, P Bagci, D Ozdemir, S Balci, JM Sarmiento, ...
The American journal of surgical pathology 38 (4), 480, 2014
542014
Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis
H Kim, B Saka, S Knight, M Borges, E Childs, A Klein, C Wolfgang, ...
Clinical cancer research 20 (7), 1865-1872, 2014
512014
CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer
LE Colbert, AV Petrova, SB Fisher, BG Pantazides, MZ Madden, ...
Cancer research 74 (10), 2677-2687, 2014
482014
KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas
AM Krasinskas, AJ Moser, B Saka, NV Adsay, SI Chiosea
Modern Pathology 26 (10), 1346-1354, 2013
472013
Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases
AM Schlitter, KT Jang, G Klöppel, B Saka, SM Hong, H Choi, GJ Offerhaus, ...
Modern Pathology 28 (9), 1249-1264, 2015
462015
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma
A Schueneman, M Goggins, J Ensor, B Saka, N Neishaboori, S Lee, ...
British journal of cancer 113 (1), 64-68, 2015
332015
Substaging nodal status in ampullary carcinomas has significant prognostic value: proposed revised staging based on an analysis of 313 well-characterized cases
S Balci, O Basturk, B Saka, P Bagci, LM Postlewait, T Tajiri, KT Jang, ...
Annals of surgical oncology 22 (13), 4392-4401, 2015
282015
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer
WA Hall, AV Petrova, LE Colbert, CW Hardy, SB Fisher, B Saka, ...
Oncogene 33 (47), 5450-5456, 2014
242014
Erbarut Seven I, Dursun N, Balci S, Gucer H, Jang KT, Tajiri T, Basturk O, Kong SY, Goodman M, et al. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a …
MD Reid, P Bagci, N Ohike, B Saka
Mod Pathol 28, 686-94, 2015
232015
Criteria for pathologic sampling of gallbladder specimens
V Adsay, B Saka, O Basturk, JC Roa, A Renshaw, E Gould
American journal of clinical pathology 140 (2), 278-280, 2013
202013
High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma
LE Colbert, SB Fisher, S Balci, B Saka, Z Chen, S Kim, BF El-Rayes, ...
International Journal of Radiation Oncology* Biology* Physics 91 (3), 631-639, 2015
192015
The system can't perform the operation now. Try again later.
Articles 1–20